SMILE治疗大散光2a的疗效观察
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Clinical study of SMILE on the correction of large astigmatism for 2a
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察小切口基质内透镜取出术(small incision lenticule extraction,SMILE)治疗大散光患者的2a临床疗效。

    方法:回顾性分析在我院手术的大散光患者17例33眼,年龄18~36岁,其中散光-3.50~-4.00D者12例24眼,散光-4.25~-5.00D 5例9眼; 合并球镜+1.00~0D者4例7眼,合并-1.00~0D者13例26眼。采用小切口基质内透镜取出术,手术切口长度为2mm,位于120°,角膜帽的厚度均为120μm,透镜直径6.6~6.8mm,帽直径为7.3~7.5mm。观察时间点为术后1d,1wk,1、3、6mo,1、2a。分别观察术后裸眼视力、术后等效球镜、残余残光度数、角膜地形图SimK平均值及SimK值的差值。

    结果:与术前裸眼视力相比,术后1d裸眼视力差异有统计学意义(P<0.05),与术后1wk裸眼视力相比,术后1、3、6mo,1、2a差异均无统计学意义(P>0.05)。裸眼视力均无增加或减少两行及以上,目标屈光度为+0.25D。与术后1d相比,术后各时间点等效球镜及残余散光差异均无统计学意义(P>0.05)。术后各时间点SimK等效值、SimK差值差异无统计学意义(P>0.05)。

    结论:远期观察SMILE治疗大散光均安全有效,稳定性及可预期高,术后2a角膜形态良好,值得临床应用。

    Abstract:

    AIM: To observe the surgical results of large astigmatism with small incision lenticule extraction(SMILE)for 2a.

    METHODS: Totally 33 eyes of 17 consecutive patients were enrolled in this retrospective study, aged from 18 to 36 years old, which included 24 eyes of 12 patients with astigmatism within -3.50D to -4.00D and 9 eyes of 5 patients within -4.25D to -5.00D, 7 eyes of 4 patients with sphere within 0 to +1.00D and 26 eyes of 13 patients within -1.00D to 0. Intended cap diameters was 7.3-7.5mm, lenticule diameter was 6.6-6.8mm, the thickness of cap was 120μm, the surgical incision was 2mm. We observed the results after 1d, 1wk, 1, 3, 6mo, 1 and 2a. Preoperative best corrected visual acuity, spherical equivalent refraction, postoperative uncorrected visual acuity, SimK equivalent value and SimK value was observed.

    RESULTS: Compared with preoperation, uncorrected visual acuity showed significant difference statistically at 1d postoperatively(P<0.05). Compared with 1wk postoperatively, uncorrected visual acuity showed no significant difference statistically at postoperative 1, 3, 6mo, 1 and 2a(P>0.05). Uncorrected visual acuity did not increase or decrease more than two lines. The target diopter was +0.25D. Compared with 1d postoperatively, the spherical equivalent refraction and residual astigmatism showed no significant difference statistically at each postoperative period(P>0.05). postoperative SimK equivalent value and SimK value difference showed no significant difference statistically compared with each postoperative period(P>0.05).

    CONCLUSION: It is both safe, effective, predictable and stable to correct large astigmatism with SMILE by long-term observation, postoperative 2a. The corneal morphology is good and worthy of clinical application.

    参考文献
    相似文献
    引证文献
引用本文

李庆和,李岳美,齐绍文. SMILE治疗大散光2a的疗效观察.国际眼科杂志, 2018,18(6):1153-1156.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2017-11-28
  • 最后修改日期:2018-05-11
  • 录用日期:
  • 在线发布日期: 2018-05-25
  • 出版日期:
文章二维码